FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $105 | +12.9% | 230,600 | +17.4% | 0.00% | – |
| Q4 2022 | $93 | -99.9% | 196,390 | -8.2% | 0.00% | – |
| Q3 2022 | $150,000 | -35.1% | 214,000 | -19.3% | 0.00% | – |
| Q2 2022 | $231,000 | -53.8% | 265,223 | -40.6% | 0.00% | -100.0% |
| Q1 2022 | $500,000 | +20.2% | 446,412 | +112.5% | 0.00% | 0.0% |
| Q4 2021 | $416,000 | -37.3% | 210,100 | +8.0% | 0.00% | 0.0% |
| Q3 2021 | $663,000 | – | 194,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,361,064 | $24,853,000 | 7.00% |
| Novo Holdings A/S | 2,361,229 | $43,116,000 | 1.85% |
| Ally Bridge Group (NY) LLC | 425,000 | $7,761,000 | 1.33% |
| TFG Asset Management GP Ltd | 750,000 | $13,695,000 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 657,494 | $12,006,000 | 0.85% |
| FRAZIER MANAGEMENT LLC | 550,000 | $10,043,000 | 0.77% |
| Eventide Asset Management | 2,485,656 | $44,266,000 | 0.68% |
| Ovata Capital Management Ltd | 14,981 | $274,000 | 0.09% |
| AXA S.A. | 551,476 | $10,070,000 | 0.03% |
| Woodline Partners LP | 25,932 | $474,000 | 0.01% |